GB0006525D0 — Inhaler
Assigned to AstraZeneca UK Ltd · Expires 2000-05-10 · 26y expired
What this patent protects
An inhaler for delivery of medicament from a canister (2) which is compressible to deliver a dose of medicament. The inhaler comprises: a housing (1) for holding a canister (2); a canister engagement lever (10) engageable with a canister (2) held in the housing to compress the ca…
USPTO Abstract
An inhaler for delivery of medicament from a canister (2) which is compressible to deliver a dose of medicament. The inhaler comprises: a housing (1) for holding a canister (2); a canister engagement lever (10) engageable with a canister (2) held in the housing to compress the canister (2); a loading mechanism for loading a resilient loading element (7) which is arranged, when loaded, to bias the canister engagement lever (10) to compress the canister (2); and a triggering mechanism arranged to hold the canister engagement lever (10) against compression of the canister (2) and triggerable to release the canister engagement lever (10). The linkage between the resilient loading element (7) and the canister engagement lever (10) is arranged to reduce the force applied by the canister engagement lever (10) to the triggering mechanism when held by the triggering mechanism.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.